Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

Colorectal adenoma characteristics as predictors of recurrence.

Bonithon-Kopp C, Piard F, Fenger C, Cabeza E, O'Morain C, Kronborg O, Faivre J; European Cancer Prevention Organisation Study Group.

Dis Colon Rectum. 2004 Mar;47(3):323-33.

PMID:
14991494
2.

Adenoma characteristics as risk factors for recurrence of advanced adenomas.

Martínez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS.

Gastroenterology. 2001 Apr;120(5):1077-83.

PMID:
11266371
3.
4.

Predicting proximal advanced neoplasms at screening sigmoidoscopy.

Senore C, Segnan N, Bonelli L, Sciallero S, Pennazio M, Angioli D, Crosta C, Gasperoni S, Malfitana G; SCORE Working Group.

Dis Colon Rectum. 2004 Aug;47(8):1331-40.

PMID:
15484347
5.

High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics.

Gschwantler M, Kriwanek S, Langner E, Göritzer B, Schrutka-Kölbl C, Brownstone E, Feichtinger H, Weiss W.

Eur J Gastroenterol Hepatol. 2002 Feb;14(2):183-8.

PMID:
11981343
6.

Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum.

Yang G, Zheng W, Sun QR, Shu XO, Li WD, Yu H, Shen GF, Shen YZ, Potter JD, Zheng S.

J Natl Cancer Inst. 1998 Nov 4;90(21):1661-5.

PMID:
9811316
7.

Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.

Alberts DS, Martínez ME, Roe DJ, Guillén-Rodríguez JM, Marshall JR, van Leeuwen JB, Reid ME, Ritenbaugh C, Vargas PA, Bhattacharyya AB, Earnest DL, Sampliner RE.

N Engl J Med. 2000 Apr 20;342(16):1156-62.

8.

New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy.

Avidan B, Sonnenberg A, Schnell TG, Leya J, Metz A, Sontag SJ.

Am J Gastroenterol. 2002 Jun;97(6):1524-9.

PMID:
12094877
9.

Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.

Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER.

N Engl J Med. 1999 Jan 14;340(2):101-7.

10.

Characteristics of metachronous colorectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence.

Nusko G, Hahn EG, Mansmann U.

Scand J Gastroenterol. 2009;44(6):736-44. doi: 10.1080/00365520902770078.

PMID:
19277927
11.
12.

Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.

Chung SJ, Kim YS, Yang SY, Song JH, Kim D, Park MJ, Kim SG, Song IS, Kim JS.

Gut. 2011 Nov;60(11):1537-43. doi: 10.1136/gut.2010.232876. Epub 2011 Mar 22.

PMID:
21427200
13.

Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial.

Cottet V, Bonithon-Kopp C, Kronborg O, Santos L, Andreatta R, Boutron-Ruault MC, Faivre J; European Cancer Prevention Organisation Study Group.

Eur J Cancer Prev. 2005 Feb;14(1):21-9.

PMID:
15677892
14.
15.

Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.

Atkin WS, Morson BC, Cuzick J.

N Engl J Med. 1992 Mar 5;326(10):658-62.

16.

A randomized trial of aspirin to prevent colorectal adenomas.

Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU.

N Engl J Med. 2003 Mar 6;348(10):891-9.

17.

Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P; Phoenix and Tucson Gastroenterologist Networks.

J Natl Cancer Inst. 2005 Jun 1;97(11):846-53.

PMID:
15928305
19.

Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.

Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, Robinson MH, Logan RF.

Gut. 2001 Jul;49(1):91-6.

20.

Supplemental Content

Support Center